Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer

Clinical trial NCT01359397 · UNKNOWN

Trial details

NCT number: NCT01359397
Sponsor: The Netherlands Cancer Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Gastric Cancer Adenocarcinoma of the Gastro-oesophageal Junction

Start date: 2011-03-01
Primary completion: 2015-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.